Rimegepant/BHV3000 clinical trials

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

This study is testing a new medication (rimegepant) for children and teenagers aged 6 to 17 who experience migraines. Researchers want to see if it's safe and effective compared to a dummy pill to relieve moderate to severe migraine attacks.